Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.45 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18104469 | 0.94 | ELANE (0.56) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL19881850 | 0.94 | ELANE (0.56) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL4946215 | 0.94 | ELANE (0.56) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL56436 | 0.91 | ELANE (0.69) | ELANEMAPTKMT2AATMSMN1; SMN2 | |
| SCHEMBL2404682 | 0.91 | ELANE (0.76) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL18061416 | 0.89 | ELANE (0.51) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL11558754 | 0.89 | MAPT (0.57) | ELANEMAPTKMT2AATMSMN1; SMN2 | |
| SCHEMBL12234115 | 0.89 | ELANE (0.51) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL687176 | 0.89 | ELANE (0.51) | ELANEMAPTKMT2AATMCES2 | |
| SCHEMBL10015754 | 0.89 | ELANE (0.59) | ELANEMAPTKMT2AATMCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113795787-B | Color electrophoretic display | 伊英克公司 | 2024-10-18 | — | — | CN | claimed |
| CN-114585656-B | Method and system for preparing high molecular weight ethylene-based polymers | 埃克森美孚化学专利公司 | 2024-03-05 | — | — | CN | claimed |
| US-20220413323-A1 | COMPOSITE ELECTROPHORETIC PARTICLES HAVING POLYMER SHELLS INCLUDING FIRST AND SECOND MONOMERIC UNITS | E INK CORPORATION | 2022-12-29 | — | — | US | claimed |
| CN-115322100-A | Delta, epsilon-alkenyl ketone compound and preparation method and application thereof | 南京工业大学 | 2022-11-11 | — | — | CN | claimed |
| US-11460722-B2 | Colored electrophoretic displays | E INK CORPORATION (US) | 2022-10-04 | — | — | US | claimed |
| CN-114585656-A | Process and system for preparing high molecular weight ethylene-based polymers | 埃克森美孚化学专利公司 | 2022-06-03 | — | — | CN | claimed |
| EP-3966630-A1 | COLORED ELECTROPHORETIC DISPLAYS | E Ink Corporation (US) | 2022-03-16 | — | — | EP | claimed |
| CN-113795787-A | Color electrophoretic display | 伊英克公司 | 2021-12-14 | — | — | CN | claimed |
| CN-113200856-A | Trifluoromethyl propylene compound and preparation method and application thereof | 南京工业大学 | 2021-08-03 | — | — | CN | claimed |
| WO-2020231733-A1 | COLORED ELECTROPHORETIC DISPLAYS | E INK CORPORATION (US) | 2020-11-19 | — | — | WO | claimed |
| US-20050220840-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220841-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220839-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20050220843-A1 | Coating compositions for bioactive agents | Surmodics Coatings, LLC | 2005-10-06 | — | — | US | claimed |
| US-20030225230-A1 | Polymers for antifouling coatings and a process for the preparation thereof | JOTUN A/S | 2003-12-04 | — | — | US | claimed |
| EP-0841380-B1 | Method of making polymeric binders and use thereof in antifouling paints | WITCO GMBH (DE) | 1999-08-25 | — | — | EP | claimed |
| US-5891935-A | Process for preparing polymeric binders and their use for antifouling paint systems | WITCO GMBH (DE) | 1999-04-06 | — | — | US | claimed |
| EP-0833870-A1 | POLYMERS FOR ANTIFOULING COATINGS AND A PROCESS FOR THE PREPARATION THEREOF | Jotun A/S (NO) | 1998-04-08 | — | — | EP | claimed |
| WO-1996041842-A1 | POLYMERS FOR ANTIFOULING COATINGS AND A PROCESS FOR THE PREPARATION THEREOF | JOTUN A/S (NO) | 1996-12-27 | — | — | WO | claimed |
| US-5374487-A | Compatible polymeric mixtures | ROHM GMBH (DE) | 1994-12-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050220839-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ELANE 257/4885MAPT 3986/4885KMT2A 4075/4885 |
| US-20050220841-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ELANE 257/4885MAPT 3986/4885KMT2A 4075/4885 |
| US-20050220843-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ELANE 257/4885MAPT 3986/4885KMT2A 4075/4885 |
| US-20050220840-A1 | Coating compositions for bioactive agents | BMP2, FGF23, TGFB1 | ELANE 257/4885MAPT 3986/4885KMT2A 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.